| Literature DB >> 35577830 |
Kosaku Komiya1,2, Takashi Yamamoto3, Hiroki Yoshikawa4,3, Akihiko Goto3, Kenji Umeki3, Takeshi Johkoh5, Kazufumi Hiramatsu6, Jun-Ichi Kadota4.
Abstract
Although lung involvement in aspiration pneumonia typically has a gravity-dependent distribution on chest images, which patient's conditions contribute to its radiological pattern has not been fully elucidated. This study was designed to determine the factors associated with the gravity-dependent distribution of community-acquired pneumonia (CAP) on chest computed tomography (CT). This retrospective study included elderly patients aged ≥ 65 years with CAP who underwent chest CT within 1 week before or after admission. The factors associated with lower lobe- and posterior-predominant distributions of ground glass opacity or airspace consolidation were determined. Of the 369 patients with CAP, 348 (94%) underwent chest CT. Multivariate analyses showed that impaired consciousness, a low Barthel index of activities of daily living, and high hemoglobin levels were associated with lower lobe-predominant distribution, while male sex and impaired consciousness were associated with posterior-predominant distribution. Cerebrovascular diseases were unrelated to these distributions. While male sex, impaired consciousness, high hemoglobin levels, low albumin levels, and the number of involved lobes were associated with in-hospital mortality, gravity-dependent distributions were not. Impaired consciousness might be the most significant predictor of aspiration pneumonia; however, the gravity-dependent distribution of this disease is unlikely to affect disease prognosis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35577830 PMCID: PMC9110711 DOI: 10.1038/s41598-022-12092-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Univariate logistic regression analysis of the baseline characteristics associated with lower lobe-predominant distribution.
| Lower lobe-predominance | Non- lower lobe-predominance | OR (95% CI) | ||
|---|---|---|---|---|
| Female | 82 (46) | 90 (54) | 0.725 (0.476–1.106) | 0.135 |
| Age, yr | 86 (80–90) | 87 (81–92) | 0.992 (0.967–1.017 ) | 0.527 |
| BMI, kg/m2 | 18.4 (16.5–21.5) | 19.0 (16.4–21.9) | 0.981 (0.930–1.035) | 0.487 |
| Impaired consciousness | 46 (26) | 20 (12) | 2.540 (1.430–4.513) | 0.001 |
| Systolic blood pressure, mmHg | 119 (104–137) | 120 (104–136) | 0.998 (0.989–1.007) | 0.643 |
| Respiratory failure | 66 (37) | 86 (51) | 0.973 (0.899–1.052) | 0.488 |
| Current or former smoker | 39 (36) | 47 (28) | 1.490 (0.947–2.345) | 0.084 |
| Barthel index > 35 | 75 (42) | 92 (55) | 0.590 (0.386–0.902) | 0.015 |
| Chronic obstructive pulmonary disease | 24 (13) | 21 (13) | 1.077 (0.575–2.017) | 0.817 |
| Heart failure | 36 (20) | 37 (22) | 0.885 (0.528–1.483) | 0.643 |
| Cerebrovascular diseases | 55 (31) | 44 (26) | 1.240 (0.777–1.980) | 0.367 |
| Diabetes mellitus | 28 (16) | 17 (10) | 1.636 (0.860–3.113) | 0.134 |
| Malignancy | 9 (5) | 9 (5) | 0.930 (0.360–2.401) | 0.881 |
| White blood cells, 103/μL | 9.3 (6.6–12.8) | 9.2 (6.2–12.4) | 1.000 (1.000–1.000) | 0.666 |
| Neutrophils, 103/μL | 8.5 (5.2–12.5) | 7.4 (4.7–11.1) | 1.000 (1.000–1.000) | 0.049 |
| Hemoglobin, g/dL | 12.1 (10.8–13.4) | 11.7 (10.3–12.7) | 1.152 (1.032–1.286) | 0.011 |
| Aspartate aminotransferase, IU/L | 22 (18–32) | 23 (18–31) | 1.005 (0.995–1.014) | 0.343 |
| eGFR, mL/min/1.73 m2 | 57.1 (39.5–86.9) | 58.7 (37.1–79.6) | 1.000 (0.995–1.005) | 0.889 |
| C–reactive protein, mg/dL | 8.4 (3.2–15.5) | 6.7 (2.8–13.6) | 1.013 (0.987–1.041) | 0.323 |
| Albumin, g/dL | 3.1 (2.8–3.5) | 3.2 (2.8–3.6) | 0.888 (0.619–1.273) | 0.518 |
| Cavitary lesion | 11 (6) | 12 (7) | 0.846 (0.363–1.973) | 0.699 |
| Patchy shadow | 57 (32) | 69 (41) | 0.665 (0.428–1.032) | 0.069 |
Data are presented as number (%) or median (interquartile range).
BMI, body mass index; CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds ratio.
Multivariate logistic regression analysis of the baseline characteristics associated with lower lobe-predominant distribution.
| OR (95% CI) | ||
|---|---|---|
| Impaired consciousness | 2.139 (1.154–3.966) | 0.016 |
| The Barthel index > 35 | 0.601 (0.375–0.965) | 0.035 |
| Neutrophils, 103/μL | 1.000 (1.000–1.000) | 0.068 |
| Hemoglobin, g/dL | 1.183 (1.054–1.329) | 0.004 |
CI, confidence interval; OR, odds ratio.
Univariate logistic regression analysis of the baseline characteristics associated with posterior-predominant distribution.
| Posterior-predominance | Non-posterior-predominance | OR (95% CI) | ||
|---|---|---|---|---|
| Female | 63 (42) | 109 (55) | 0.538 (0.377–0.887) | 0.012 |
| Age, yr | 87 (81–90) | 86 (80–92) | 1.001 (0.976–1.027) | 0.921 |
| BMI, kg/m2 | 18.1 (16.2–20.9) | 19.5 (16.8–22.6) | 0.923 (0.872–0.977) | 0.006 |
| Impaired consciousness | 43 (29) | 23 (12) | 3.012 (1.720–5.275) | < 0.001 |
| Systolic blood pressure, mmHg | 117 (103–133) | 122 (106–139) | 0.993 (0.984–1.002) | 0.113 |
| Respiratory failure | 91 (60) | 101 (51) | 0.977 (0.907–1.053) | 0.550 |
| Current or former smoker | 54 (36) | 59 (30) | 1.302 (0.829–2.045) | 0.252 |
| Barthel index > 35 | 57 (38) | 110 (56) | 0.480 (0.311–0.739) | < 0.001 |
| Chronic obstructive pulmonary disease | 19 (13) | 26 (13) | 0.947 (0.502–1.784) | 0.865 |
| Heart failure | 28 (19) | 45 (23) | 0.769 (0.453–1.304) | 0.330 |
| Cerebrovascular diseases | 50 (33) | 49 (25) | 1.495 (0.936–2.388) | 0.092 |
| Diabetes mellitus | 25 (17) | 20 (10) | 1.756 (0.934–3.300) | 0.080 |
| Malignancy | 9 (6) | 9 (5) | 1.324 (0.512–3.421) | 0.562 |
| White blood cells, 103/μL | 8.8 (6.1–12.4) | 9.6 (6.5–12.7) | 1.000 (1.000–1.000) | 0.370 |
| Neutrophils, 103/μL | 7.4 (5.0–12.2) | 7.9 (5.1–11.6) | 1.000 (1.000–1.000) | 0.066 |
| Hemoglobin, g/dL | 11.6 (10.6–13.2) | 12.0 (10.3–13.1) | 1.032 (0.926–1.150) | 0.566 |
| Aspartate aminotransferase, IU/L | 22 (18–31) | 23 (18–32) | 1.003 (0.994–1.013) | 0.466 |
| eGFR, mL/min/1.73 m2 | 56.8 (37.5–88.0) | 58.9 (40.8–79.1) | 1.003 (0.998–1.008) | 0.218 |
| C-reactive protein, mg/dL | 8.9 (3.7–15.6) | 6.6 (2.4–13.6) | 1.017 (0.991–1.045) | 0.200 |
| Albumin, g/dL | 3.1 (2.7–3.4) | 3.3 (2.9–3.7) | 0.581 (0.400–0.845) | 0.005 |
| Cavitary lesion | 11 (7) | 12 (6) | 1.1211 (0.519–2.826) | 0.657 |
| Patchy shadow | 60 (40) | 66 (34) | 1.309 (0.843–2.032) | 0.231 |
Data are presented as number (%) or median (interquartile range).
BMI, body mass index; CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds ratio.
Multivariate logistic regression analysis of the baseline characteristics associated with posterior-predominant distribution.
| OR (95% CI) | ||
|---|---|---|
| Female | 0.474 (0.296–0.758) | 0.002 |
| BMI, kg/m2 | 0.953 (0.896–1.014) | 0.126 |
| Impaired consciousness | 2.385 (1.277–4.456) | 0.006 |
| Barthel index > 35 | 0.619 (0.373–1.029) | 0.064 |
| Albumin, g/dL | 0.742 (0.492–1.118) | 0.153 |
CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds ratio.
Univariate Cox hazard regression analysis of the baseline characteristics and radiological features associated with in-hospital mortality.
| Non-survivor | Survivor | HR (95% CI) | ||
|---|---|---|---|---|
| Female | 22 (37) | 150 (52) | 0.552 (0.323–0.944) | 0.030 |
| Age, yr | 88 (84–92) | 86 (79–91) | 1.036 (1.000–1.073) | 0.051 |
| BMI, kg/m2 | 17.8 (15.0–20.3) | 18.9 (16.9–21.9) | 0.943 (0.878–1.013) | 0.109 |
| Impaired consciousness | 21 (36) | 45 (16) | 2.110 (1.233–3.610) | 0.006 |
| Systolic blood pressure, mmHg | 115 (100–131) | 121 (104–139) | 0.995 (0.985–1.006) | 0.383 |
| Respiratory failure | 47 (80) | 145 (50) | 1.003 (0.938–1.072) | 0.931 |
| Current or former smoker | 23 (39) | 90 (31) | 1.352 (0.797–2.292) | 0.263 |
| Barthel index > 35 | 20 (34) | 147 (51) | 0.666 (0.388–1.144) | 0.141 |
| Chronic obstructive pulmonary disease | 6 (10) | 39 (14) | 0.847 (0.363–1.977) | 0.702 |
| Heart failure | 18 (31) | 55 (19) | 1.213 (0.692–2.128) | 0.500 |
| Cerebrovascular diseases | 20 (34) | 79 (27) | 1.057 (0.613–1.821) | 0.843 |
| Diabetes Mellitus | 5 (9) | 40 (14) | 0.564 (0.225–1.413) | 0.221 |
| Malignancy | 6 (10) | 12 (4) | 2.198 (0.941–5.133) | 0.069 |
| White blood cells, 103/μL | 8.7 (5.8–14.1) | 9.2 (6.5–12.4) | 1.000 (1.000–1.000) | 0.536 |
| Neutrophils, 103/μL | 7.2 (4.7–13.1) | 7.9 (5.1–11.6) | 1.000 (1.000–1.000) | 0.688 |
| Hemoglobin, g/dL | 10.9 (9.8–12.1) | 12.0 (10.7–13.2) | 0.849 (0.749–0.963) | 0.011 |
| Aspartate aminotransferase, IU/L | 26 (18–37) | 22 (18–31) | 1.010 (1.003–1.017) | 0.007 |
| eGFR, mL/min/1.73 m2 | 54.3 (32.7–93.7) | 58.3 (38.5–80.1) | 1.001 (0.995–1.006) | 0.810 |
| C-reactive protein, mg/dL | 7.7 (3.9–17.2) | 7.6 (2.9–14.0) | 1.010 (0.981–1.039) | 0.514 |
| Albumin, g/dL | 2.8 (2.2–3.2) | 3.3 (2.9–3.6) | 0.325 (0.205–0.515) | < 0.001 |
| Lower lobe-predominance | 30 (51) | 150 (52) | 0.745 (0.443–1.252) | 0.266 |
| Posterior-predominance | 30 (51) | 121 (42) | 1.098 (0.654–1.841) | 0.724 |
| Cavitary lesion | 7 (12) | 16 (6) | 1.415 (0.631–3.173) | 0.399 |
| Patchy shadow | 25 (42) | 101 (35) | 1.272 (0.754–2.147) | 0.367 |
| Number of involved lobes | 4 (3–5) | 3 (2–5) | 1.207 (1.008–1.446) | 0.041 |
Data are presented as the number (%) or median (interquartile range).
BMI, body mass index; CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio.
Multivariate Cox hazard regression analysis of the baseline characteristics associated with in-hospital mortality.
| HR (95% CI) | ||
|---|---|---|
| Female | 0.449 (0.237–0.814) | 0.009 |
| Impaired consciousness | 2.353 (1.279–4.327) | 0.006 |
| Hemoglobin, g/dL | 0.851 (0.733–0.989) | 0.035 |
| Aspartate aminotransferase, IU/L | 1.002 (0.994–1.011) | 0.610 |
| Albumin, g/dL | 0.471 (0.286–0.777) | 0.003 |
| Number of involved lobes | 1.229 (1.019–1.482) | 0.031 |
CI, confidence interval; HR: hazard ratio.